Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1990-3-12
|
pubmed:abstractText |
Fragments of the parathyroid hormone (PTH) molecule were investigated for intrinsic antinociceptive effects and modulation of salmon calcitonin- and morphine-induced antinociception. Intraventricularly administered PTH 1-34 produced naloxone-insensitive antinociception in both the tail-flick and hot-plate tests. PTH 1-34 antinociceptive effects in the tail-flick test were blocked by i.c.v. salmon calcitonin (sCT, 2 micrograms) and i.c.v. calcium chloride (0.12 mumol). [tyrosine-34]b-PTH (7-34)NH2, the PTH antagonist, did not block PTH 1-34-induced antinociception. PTH 1-34 (2 micrograms) was additive with antinociceptive doses of sCT, but not morphine, in the hot-plate test. PTH 44-68 (0.3 micrograms/mouse, icv.) produced hyperalgesic effects 30 min after administration using the hot-plate test. PTH 44-68 (2 micrograms/mouse) attenuated sCT-induced but not morphine-induced antinociception in both the hot-plate and tail-flick tests. PTH 64-84 was inactive in all tests, alone or in combination with sCT or morphine. Due to the low efficacy of PTH 1-34 and 44-68 in antinociceptive tests, these PTH fragments may act as modulators of antinociception rather than directly producing antinociceptive or hyperalgesic effects. In addition, the results indicate that sCT and the PTH fragments 1-34 and 44-68 may interact in the modulation of nonopiate antinociception, possibly via opposing actions on calcium in the brain.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics,
http://linkedlifedata.com/resource/pubmed/chemical/Calcitonin,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Morphine,
http://linkedlifedata.com/resource/pubmed/chemical/Parathyroid Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/salmon calcitonin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-3565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
252
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
140-6
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2299586-Analgesics,
pubmed-meshheading:2299586-Animals,
pubmed-meshheading:2299586-Calcitonin,
pubmed-meshheading:2299586-Calcium,
pubmed-meshheading:2299586-Dose-Response Relationship, Drug,
pubmed-meshheading:2299586-Drug Interactions,
pubmed-meshheading:2299586-Hyperalgesia,
pubmed-meshheading:2299586-Male,
pubmed-meshheading:2299586-Mice,
pubmed-meshheading:2299586-Morphine,
pubmed-meshheading:2299586-Parathyroid Hormone,
pubmed-meshheading:2299586-Peptide Fragments
|
pubmed:year |
1990
|
pubmed:articleTitle |
The activity of several peptide fragments of parathyroid hormone, alone and in combination with salmon calcitonin and morphine, in antinociceptive tests in the mouse.
|
pubmed:affiliation |
Department of Pharmacology & Toxicology, Medical College of Virginia, Richmond.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|